190 related articles for article (PubMed ID: 7722325)
1. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
Høgåsen AK; Würzner R; Abrahamsen TG; Dierich MP
J Immunol; 1995 May; 154(9):4734-40. PubMed ID: 7722325
[TBL] [Abstract][Full Text] [Related]
2. Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes.
Lukasser-Vogl E; Gruber A; Lass-Flörl C; Eder A; Høgåsen AK; Morgan BP; Dierich MP; Würzner R
FEMS Immunol Med Microbiol; 2000 May; 28(1):15-23. PubMed ID: 10767603
[TBL] [Abstract][Full Text] [Related]
3. Purification of the sixth and seventh component of human complement without loss of hemolytic activity.
Podack ER; Kolb WP; Müller-Eberhard HJ
J Immunol; 1976 Feb; 116(2):263-9. PubMed ID: 1249415
[TBL] [Abstract][Full Text] [Related]
4. Terminal complement components play a role in the expression of C5a.
Gresham HD; Renfer L; Hammer CH; Frank MM
J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
[TBL] [Abstract][Full Text] [Related]
5. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
Hetland G; Bungum L
APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
[TBL] [Abstract][Full Text] [Related]
6. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
7. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines.
Gasque P; Fontaine M; Morgan BP
J Immunol; 1995 May; 154(9):4726-33. PubMed ID: 7536777
[TBL] [Abstract][Full Text] [Related]
8. Structural similarities between C6 and C7 of human complement.
Podack ER; Kolb WP; Esser AF; Müller-Eberhard HJ
J Immunol; 1979 Sep; 123(3):1071-7. PubMed ID: 381516
[TBL] [Abstract][Full Text] [Related]
9. The release of C5a in complement-activated serum does not require C6.
Biesecker G; Wagner JL; Hugli TE
J Immunol; 1989 Aug; 143(4):1228-32. PubMed ID: 2545783
[TBL] [Abstract][Full Text] [Related]
10. Secretion of the terminal complement proteins, C5-C9, by human platelets.
Houle JJ; Leddy JP; Rosenfeld SI
Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
[TBL] [Abstract][Full Text] [Related]
11. Importance of the terminal complement components for immune defence against Candida.
Triebel T; Grillhösl B; Kacani L; Lell CP; Fuchs A; Speth C; Lass-Flörl C; Steinmann J; Dierich MP; Würzner R
Int J Med Microbiol; 2003 Feb; 292(7-8):527-36. PubMed ID: 12635935
[TBL] [Abstract][Full Text] [Related]
12. Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.
Dessauer A; Rother U; Rother K
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():83-8. PubMed ID: 6444196
[TBL] [Abstract][Full Text] [Related]
13. C5-dependent enhancement of rosette formation and phagocytosis by human polymorphonuclear leukocytes.
Segerling M; Opferkuch W
Monogr Allergy; 1977; 12():101-4. PubMed ID: 917012
[TBL] [Abstract][Full Text] [Related]
14. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
[TBL] [Abstract][Full Text] [Related]
15. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
Hoover DL; Berger M; Hammer CH; Meltzer MS
J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of the third and fifth complement components by isolated human lung cells.
Rothman BL; Merrow M; Bamba M; Kennedy T; Kreutzer DL
Am Rev Respir Dis; 1989 Jan; 139(1):212-20. PubMed ID: 2912341
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
[TBL] [Abstract][Full Text] [Related]
18. Functional active complement components secreted by guinea pig peritoneal macrophages.
Brade V; Kreuzpaintner G
Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide is not involved in hepatocyte killing by neutrophils activated by N-formyl-methionyl-leucylphenylalanine or phorbol myristate acetate in vitro.
Wagner JG; Ganey PE; Roth RA
Hepatology; 1996 Apr; 23(4):803-10. PubMed ID: 8666335
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte complement: a possible role for C5 in lymphocyte stimulation.
Sundsmo JS
J Immunol; 1983 Aug; 131(2):886-91. PubMed ID: 6223096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
